Hormone Replacement Therapy Market Size to Reach USD 29.02 Billion by 2032
The Hormone Replacement Therapy (HRT) Market was valued at USD 18.36 billion in 2023 and is projected to reach USD 29.02 billion by 2032, growing at a CAGR of 5.31% from 2024 to 2032. Rising cases of post-menopausal complications, hormonal imbalances, and a growing geriatric population are driving demand for HRT globally. The market is fueled by increasing awareness of menopause symptoms and advancements in therapy options, including oral, parenteral, and transdermal delivery methods. North America dominates the market, supported by high prevalence rates and ongoing product innovations. However, concerns around therapy costs and potential cancer risks pose challenges. Technological advancements and R&D investments present lucrative growth opportunities in this evolving market.